No differences in the expression levels of glutamate receptor ionotropic, NMDA 2A (NMDAR2A) and glutamate decarboxylase 1 (GAD1) were observed between control and ALS cases. The gene discussed is GRIN2A; the disease is amyotrophic lateral sclerosis.